Abstract

e12516Background: An open-label, multi-center phase II trial was conducted to evaluate the efficacy and safety of combination chemotherapy with docetaxel(Detaxel)and oxaliplatin(Oxalitin) in recurr...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call